Long-term survival of patients with multiple sclerosis in West France. (Q51107810)

30 March 2018

title

Long-term survival of patients with multiple sclerosis in West France. (English)

1 reference

30 March 2018

0 references

E Leray

1

1 reference

30 March 2018

S P Morrissey

2

1 reference

30 March 2018

J Yaouanq

3

1 reference

30 March 2018

M Coustans

4

1 reference

30 March 2018

E Le Page

5

1 reference

30 March 2018

J Chaperon

6

1 reference

30 March 2018

G Edan

7

1 reference

30 March 2018

publication date

1 August 2007

1 reference

30 March 2018

Multiple Sclerosis Journal

published in

1 reference

30 March 2018

volume

13

1 reference

30 March 2018

issue

7

1 reference

30 March 2018

page(s)

865-874

1 reference

30 March 2018

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Survival in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Trends in survival and cause of death in Danish patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Multiple sclerosis in the Faroe Islands: an epitome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Survival of multiple sclerosis in Finland between 1964 and 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

The natural history of multiple sclerosis: a regional study with some longitudinal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Survival of multiple sclerosis patients in the Belgrade population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Mortality in Persons With Multiple Sclerosis in the Seattle and Los Angeles Areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

EDMUS, a European database for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507077410

21 January 2018

Identifiers

DOI

10.1177/1352458507077410

1 reference

30 March 2018

1 reference

30 March 2018